These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25344068)

  • 1. Constant rate of p53 tetramerization in response to DNA damage controls the p53 response.
    Gaglia G; Lahav G
    Mol Syst Biol; 2014 Oct; 10(10):753. PubMed ID: 25344068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and control of p53 tetramerization in individual living cells.
    Gaglia G; Guan Y; Shah JV; Lahav G
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15497-501. PubMed ID: 24006363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p53 tetramerization and nuclear export by ARC.
    Foo RS; Nam YJ; Ostreicher MJ; Metzl MD; Whelan RS; Peng CF; Ashton AW; Fu W; Mani K; Chin SF; Provenzano E; Ellis I; Figg N; Pinder S; Bennett MR; Caldas C; Kitsis RN
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20826-31. PubMed ID: 18087040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.
    Rajagopalan S; Huang F; Fersht AR
    Nucleic Acids Res; 2011 Mar; 39(6):2294-303. PubMed ID: 21097469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraslow oligomerization equilibria of p53 and its implications.
    Natan E; Hirschberg D; Morgner N; Robinson CV; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14327-32. PubMed ID: 19667193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous Leu332Gln mutation in p53 disrupts the tetramerization ability in a canine mammary gland tumor cell line.
    Ochiai K; Azakami D; Morimatsu M; Hirama H; Kawakami S; Nakagawa T; Michishita M; Egusa AS; Sasaki T; Watanabe M; Omi T
    Oncol Rep; 2018 Jul; 40(1):488-494. PubMed ID: 29750295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational detection of p53's oligomeric state by FlAsH Fluorescence.
    Webber TM; Allen AC; Ma WK; Molloy RG; Kettelkamp CN; Dow CA; Gage MJ
    Biochem Biophys Res Commun; 2009 Jun; 384(1):66-70. PubMed ID: 19393630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer.
    Tóth C; Sükösd F; Valicsek E; Herpel E; Schirmacher P; Renner M; Mader C; Tiszlavicz L; Kriegsmann J
    Int J Mol Med; 2017 Nov; 40(5):1457-1465. PubMed ID: 28949378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Situ Monitoring of p53 Protein and MDM2 Protein Interaction in Single Living Cells Using Single-Molecule Fluorescence Spectroscopy.
    Du Z; Yu J; Li F; Deng L; Wu F; Huang X; Bergstrand J; Widengren J; Dong C; Ren J
    Anal Chem; 2018 May; 90(10):6144-6151. PubMed ID: 29671327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 tetramerization: at the center of the dominant-negative effect of mutant p53.
    Gencel-Augusto J; Lozano G
    Genes Dev; 2020 Sep; 34(17-18):1128-1146. PubMed ID: 32873579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization.
    Cubillos-Rojas M; Amair-Pinedo F; Peiró-Jordán R; Bartrons R; Ventura F; Rosa JL
    J Biol Chem; 2014 May; 289(21):14782-95. PubMed ID: 24722987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J; Glas C; Schultheiss K; Moehlenbrink J; Krieghoff-Henning E; Hofmann TG
    Cancer Res; 2011 Mar; 71(6):2350-9. PubMed ID: 21248071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.
    Shieh SY; Taya Y; Prives C
    EMBO J; 1999 Apr; 18(7):1815-23. PubMed ID: 10202145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage.
    Yan S; Qiu L; Ma K; Zhang X; Zhao Y; Zhang J; Li X; Hao X; Li Z
    Oncogene; 2014 Nov; 33(47):5424-33. PubMed ID: 24240685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.
    Kamada R; Nomura T; Anderson CW; Sakaguchi K
    J Biol Chem; 2011 Jan; 286(1):252-8. PubMed ID: 20978130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption.
    Ono W; Hayashi Y; Yokoyama W; Kuroda T; Kishimoto H; Ito I; Kimura K; Akaogi K; Waku T; Yanagisawa J
    J Biol Chem; 2014 Feb; 289(8):4928-40. PubMed ID: 24375404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial regulation of p53 function by modulating its assembly.
    Inobe T; Nozaki M; Nukina N
    Biochem Biophys Res Commun; 2015 Nov; 467(2):322-7. PubMed ID: 26454170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of p53 oligomers: Tetramerization of p53 impinges on its stability.
    Luwang JW; Nair AR; Natesh R
    Biochimie; 2021 Oct; 189():99-107. PubMed ID: 34197865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 domains: structure, oligomerization, and transformation.
    Wang P; Reed M; Wang Y; Mayr G; Stenger JE; Anderson ME; Schwedes JF; Tegtmeyer P
    Mol Cell Biol; 1994 Aug; 14(8):5182-91. PubMed ID: 8035799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 53BP1 Goes Back to Its p53 Roots.
    Durocher D; Pelletier L
    Mol Cell; 2016 Oct; 64(1):3-4. PubMed ID: 27716486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.